Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 20 | 2023 | 2028 | 3.130 |
Why?
|
Heterocyclic Compounds, 3-Ring | 8 | 2023 | 217 | 2.450 |
Why?
|
Botswana | 34 | 2023 | 1034 | 2.380 |
Why?
|
Infectious Disease Transmission, Vertical | 12 | 2023 | 1331 | 2.100 |
Why?
|
HIV Infections | 38 | 2023 | 16764 | 2.080 |
Why?
|
Anti-Retroviral Agents | 12 | 2023 | 1734 | 2.040 |
Why?
|
Premature Birth | 16 | 2023 | 1702 | 1.800 |
Why?
|
Neural Tube Defects | 3 | 2019 | 253 | 1.740 |
Why?
|
Pregnancy Outcome | 17 | 2023 | 2789 | 1.690 |
Why?
|
Benzoxazines | 4 | 2020 | 306 | 1.240 |
Why?
|
Oxazines | 8 | 2023 | 302 | 1.060 |
Why?
|
HIV Seropositivity | 3 | 2023 | 966 | 1.040 |
Why?
|
Pregnancy | 45 | 2023 | 29002 | 0.900 |
Why?
|
Infant Mortality | 3 | 2016 | 749 | 0.830 |
Why?
|
Maternal-Fetal Relations | 1 | 2021 | 25 | 0.830 |
Why?
|
Placentation | 1 | 2021 | 82 | 0.800 |
Why?
|
Stillbirth | 11 | 2023 | 346 | 0.780 |
Why?
|
Anti-HIV Agents | 9 | 2022 | 4320 | 0.730 |
Why?
|
HIV Integrase Inhibitors | 2 | 2019 | 144 | 0.710 |
Why?
|
Pyridones | 7 | 2022 | 707 | 0.700 |
Why?
|
Abnormalities, Drug-Induced | 2 | 2018 | 320 | 0.630 |
Why?
|
Diarrhea, Infantile | 1 | 2016 | 109 | 0.550 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2021 | 1896 | 0.520 |
Why?
|
Breast Feeding | 3 | 2021 | 1334 | 0.500 |
Why?
|
Infant Formula | 1 | 2016 | 200 | 0.500 |
Why?
|
Piperazines | 8 | 2023 | 2480 | 0.500 |
Why?
|
Child Mortality | 1 | 2016 | 191 | 0.490 |
Why?
|
Congenital Abnormalities | 1 | 2019 | 708 | 0.480 |
Why?
|
Alkynes | 4 | 2020 | 310 | 0.480 |
Why?
|
Infant, Newborn | 22 | 2023 | 25470 | 0.460 |
Why?
|
Cyclopropanes | 4 | 2020 | 421 | 0.460 |
Why?
|
Gestational Age | 2 | 2019 | 3486 | 0.450 |
Why?
|
Respiratory System | 1 | 2016 | 553 | 0.440 |
Why?
|
Pregnancy Complications | 6 | 2023 | 2867 | 0.410 |
Why?
|
Drug Therapy, Combination | 5 | 2019 | 6478 | 0.380 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2023 | 482 | 0.380 |
Why?
|
Zidovudine | 3 | 2017 | 623 | 0.370 |
Why?
|
Mothers | 3 | 2020 | 2143 | 0.370 |
Why?
|
Postpartum Period | 1 | 2017 | 1070 | 0.370 |
Why?
|
Female | 50 | 2023 | 378853 | 0.300 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2013 | 773 | 0.300 |
Why?
|
Pneumonia | 2 | 2019 | 2102 | 0.270 |
Why?
|
Pregnant Women | 4 | 2023 | 558 | 0.270 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2393 | 0.260 |
Why?
|
Hospital Mortality | 2 | 2019 | 5305 | 0.240 |
Why?
|
Infant | 14 | 2023 | 34923 | 0.240 |
Why?
|
Humans | 53 | 2023 | 739398 | 0.210 |
Why?
|
Prevalence | 6 | 2022 | 15153 | 0.210 |
Why?
|
Infant, Small for Gestational Age | 3 | 2021 | 438 | 0.200 |
Why?
|
HIV-1 | 4 | 2022 | 6931 | 0.190 |
Why?
|
Polydactyly | 1 | 2021 | 57 | 0.190 |
Why?
|
HIV Protease Inhibitors | 1 | 2022 | 435 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 128 | 0.180 |
Why?
|
Quarantine | 1 | 2020 | 169 | 0.160 |
Why?
|
Hospitals, District | 1 | 2019 | 105 | 0.160 |
Why?
|
Obstetric Labor, Premature | 1 | 2020 | 282 | 0.160 |
Why?
|
Lymphopenia | 1 | 2020 | 286 | 0.160 |
Why?
|
Adult | 23 | 2022 | 213394 | 0.160 |
Why?
|
HIV | 5 | 2022 | 1607 | 0.150 |
Why?
|
Africa | 1 | 2019 | 666 | 0.150 |
Why?
|
Syphilis | 1 | 2019 | 225 | 0.150 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2020 | 624 | 0.140 |
Why?
|
Fetal Death | 1 | 2018 | 446 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2020 | 591 | 0.140 |
Why?
|
Antimalarials | 1 | 2022 | 913 | 0.130 |
Why?
|
Prenatal Care | 2 | 2020 | 1087 | 0.130 |
Why?
|
Virus Diseases | 1 | 2021 | 710 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1603 | 0.130 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1957 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2023 | 1152 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2021 | 0.120 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 848 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1194 | 0.120 |
Why?
|
Travel | 1 | 2019 | 787 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2907 | 0.110 |
Why?
|
Causality | 1 | 2019 | 1262 | 0.110 |
Why?
|
Malaria | 1 | 2022 | 1234 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 806 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2022 | 2971 | 0.110 |
Why?
|
Shock, Septic | 1 | 2019 | 764 | 0.110 |
Why?
|
Child | 5 | 2023 | 77033 | 0.100 |
Why?
|
Population Surveillance | 2 | 2019 | 2629 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1877 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1498 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12328 | 0.090 |
Why?
|
Feces | 1 | 2016 | 1389 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4935 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3151 | 0.090 |
Why?
|
Prospective Studies | 5 | 2020 | 53037 | 0.090 |
Why?
|
Young Adult | 9 | 2022 | 56255 | 0.080 |
Why?
|
Medication Adherence | 2 | 2018 | 2047 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2013 | 2974 | 0.080 |
Why?
|
Risk Assessment | 3 | 2018 | 23294 | 0.080 |
Why?
|
Cause of Death | 2 | 2019 | 3564 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7136 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7726 | 0.070 |
Why?
|
Bacteria | 1 | 2016 | 2106 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5128 | 0.060 |
Why?
|
Folic Acid | 2 | 2022 | 1297 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3722 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10208 | 0.060 |
Why?
|
Risk Factors | 5 | 2023 | 71974 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4546 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9812 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10247 | 0.060 |
Why?
|
Iron | 2 | 2022 | 1776 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4671 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2021 | 21694 | 0.060 |
Why?
|
Male | 9 | 2023 | 349022 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Fertilization | 1 | 2023 | 196 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
Compassionate Use Trials | 1 | 2021 | 46 | 0.050 |
Why?
|
Chloroquine | 1 | 2022 | 280 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2021 | 79 | 0.050 |
Why?
|
Teratogens | 1 | 2021 | 113 | 0.050 |
Why?
|
E-Selectin | 1 | 2023 | 577 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 324 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2023 | 705 | 0.050 |
Why?
|
Toes | 1 | 2021 | 208 | 0.050 |
Why?
|
Maternal Mortality | 1 | 2022 | 312 | 0.040 |
Why?
|
Vitamin B 6 | 1 | 2021 | 237 | 0.040 |
Why?
|
Cervical Length Measurement | 1 | 2020 | 41 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 277 | 0.040 |
Why?
|
Clinical Audit | 1 | 2019 | 31 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 578 | 0.040 |
Why?
|
Micronutrients | 1 | 2022 | 364 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 365 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1153 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2019 | 63 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 733 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2021 | 568 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 589 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2021 | 527 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 791 | 0.040 |
Why?
|
Fingers | 1 | 2021 | 511 | 0.040 |
Why?
|
Selection Bias | 1 | 2019 | 370 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2021 | 11985 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 40389 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 732 | 0.040 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2021 | 363 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1678 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 683 | 0.040 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2021 | 947 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2021 | 595 | 0.040 |
Why?
|
Tachycardia | 1 | 2019 | 621 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2019 | 415 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1763 | 0.030 |
Why?
|
Parturition | 1 | 2019 | 431 | 0.030 |
Why?
|
Labor, Induced | 1 | 2016 | 146 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2022 | 1309 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 591 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 38942 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2062 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 853 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1682 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 40802 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 914 | 0.030 |
Why?
|
Hypotension | 1 | 2019 | 881 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3299 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2017 | 591 | 0.030 |
Why?
|
Health Services Research | 1 | 2019 | 1832 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2039 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1054 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1197 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3279 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3752 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5076 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4374 | 0.020 |
Why?
|
Drug Utilization | 1 | 2015 | 1181 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2527 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2626 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 76631 | 0.020 |
Why?
|
Rats | 1 | 2021 | 24270 | 0.020 |
Why?
|
Public Health | 1 | 2018 | 2587 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13880 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9259 | 0.020 |
Why?
|
United States | 2 | 2022 | 69573 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85405 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 212863 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 24714 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7274 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15511 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57650 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168368 | 0.010 |
Why?
|
Aged | 1 | 2019 | 162698 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_